GUJARAT THEMIS BIOSYN
Back to Balance Sheet
|
GUJARAT THEMIS BIOSYN Last 5 Year Total Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹36 Cr | ₹36 Cr | ₹32 Cr | ₹26 Cr | ₹24 Cr |
What is the latest Total Current Liabilities ratio of GUJARAT THEMIS BIOSYN ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹36 Cr |
Mar2023 | ₹36 Cr |
Mar2022 | ₹32 Cr |
Mar2021 | ₹26 Cr |
Mar2020 | ₹24 Cr |
How is Total Current Liabilities of GUJARAT THEMIS BIOSYN Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹36 Cr | 1.39 | |
Mar2023 | ₹36 Cr | 12.71 | |
Mar2022 | ₹32 Cr | 22.45 | |
Mar2021 | ₹26 Cr | 6.49 | |
Mar2020 | ₹24 Cr | - |
Compare Total Current Liabilities of peers of GUJARAT THEMIS BIOSYN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GUJARAT THEMIS BIOSYN | ₹2,839.5 Cr | -9.7% | -19.3% | 19.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,044.0 Cr | -0.2% | -1% | 9.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,537.0 Cr | -2.1% | 1.5% | 61.3% | Stock Analytics | |
CIPLA | ₹118,889.0 Cr | -0% | 2% | -0.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,075.0 Cr | -1.4% | -6.1% | -4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,832.5 Cr | -5.2% | -4.7% | 8.9% | Stock Analytics |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUJARAT THEMIS BIOSYN | -9.7% |
-19.3% |
19.9% |
SENSEX | -2.5% |
-0.8% |
7.1% |
You may also like the below Video Courses